Skip to main content
. 2005 Aug;43(8):3829–3834. doi: 10.1128/JCM.43.8.3829-3834.2005

TABLE 5.

Susceptibility test results for VITEK 2 and Phoenix

Bacterial group Antibiotic(s) No. of isolates testeda
Total no. of isolates VITEK 2
Phoenix
S I R n
%
n
%
mE ME VME mE ME VME CA mE ME VME mE ME VME CA
Enterobacteriaceae Ampicillin 24 4 113 141 1 0.7 0.0 0.0 99.3 3 1 2.1 4.2 0.0 97.2
Piperacillin 90 11 40 141 4 2 2.8 0.0 5.0 95.7 4 2.8 0.0 0.0 97.2
Piperacillin-tazobactam 121 8 12 141 11 7.8 0.0 0.0 92.2 7 1 5.0 0.8 0.0 94.3
Cefazolin 42 7 92 141 9 4 6.4 0.0 4.3 90.8 4 2 2.8 0.0 2.2 95.7
Cefepime 134 1 6 141 2 1 1.4 0.0 16.7 97.9 3 2.1 0.0 0.0 97.9
Cefuroxim 60 16 65 141 3 2.1 0.0 0.0 97.9 0.0 0.0 0.0 100.0
Cefotaxime 124 4 13 141 5 3.5 0.0 0.0 96.5 8 5.7 0.0 0.0 94.3
Ceftazidime 125 4 12 141 6 4.3 0.0 0.0 95.7 5 3.5 0.0 0.0 96.5
Meropenem 141 0 0 141 0.0 0.0 0.0 00.0 0.0 0.0 0.0 100.0
Ciprofloxacin 113 3 25 141 3 2.1 0.0 0.0 97.9 7 5.0 0.0 0.0 95.0
Levofloxacin 114 9 18 141 13 9.2 0.0 0.0 90.8 9 6.4 0.0 0.0 93.6
Gentamicin 120 4 17 141 5 3.5 0.0 0.0 96.5 6 4.3 0.0 0.0 95.7
Total 1,208 71 413 1,692 62 0 7 3.7 0.0 1.7 95.9 56 2 2 3.3 0.2 0.5 96.5
Nonfermenters Piperacillin 13 2 7 22 1 0.0 0.0 14.3 95.5 1 4.5 0.0 0.0 95.5
Piperacillin-tazobactam 18 0 4 22 1 4.5 0.0 0.0 95.5 2 9.1 0.0 0.0 90.9
Cefepime 17 3 2 22 4 18.2 0.0 0.0 81.8 5 22.7 0.0 0.0 77.3
Cefotaxime 5 6 11 22 3 13.6 0.0 0.0 86.4 4 1 18.2 0.0 9.1 77.3
Ceftazidime 14 4 4 22 5 1 22.7 0.0 25.0 72.7 3 1 13.6 0.0 25.0 81.8
Meropenem 17 2 3 22 4 1 18.2 0.0 33.3 77.3 6 27.3 0.0 0.0 72.7
Ciprofloxacin 11 2 9 22 2 9.1 0.0 0.0 90.9 1 4.5 0.0 0.0 95.5
Levofloxacin 11 4 7 22 3 13.6 0.0 0.0 86.4 4 18.2 0.0 0.0 81.8
Gentamicin 16 0 6 22 1 4.5 0.0 0.0 95.5 2 9.1 0.0 0.0 90.9
Total 122 23 53 198 23 0 3 11.6 0.0 5.7 86.9 28 0 2 14.1 0.0 3.8 84.8
Staphylococci Penicillin 31 0 62 93 0.0 0.0 0.0 100.0 0.0 0.0 0.0 100.0
Oxacillin 57 0 36 93 0.0 0.0 0.0 100.0 1 0.0 1.8 0.0 98.9
Vancomycin 93 0 0 93 0.0 0.0 0.0 100.0 0.0 0.0 0.0 100.0
Teicoplanin 93 0 0 93 0.0 0.0 0.0 100.0 1 1.1 0.0 0.0 98.9
Ofloxacin 55 0 38 93 0.0 0.0 0.0 100.0 1 1.1 0.0 0.0 98.9
Ciprofloxacin 56 0 37 93 1 0.0 1.8 0.0 98.9 0.0 0.0 0.0 100.0
Tetracycline 82 0 11 93 1 0.0 0.0 9.1 98.9 1 1 1.1 0.0 9.1 97.8
Gentamicin 74 0 19 93 1 1.1 0.0 0.0 98.9 1 1 1.1 1.4 0.0 97.8
Erythromycin 42 1 50 93 3 1 3.2 0.0 0.0 95.7 2 2.2 0.0 0.0 97.8
Clindamycin 63 0 30 93 0.0 0.0 0.0 100.0 1 1 1.1 1.6 0.0 97.8
Cotrimoxazol 81 11 1 93 1 1 0.0 1.2 0.0 97.8 1 0.0 1.2 0.0 98.9
Rifampicin 92 1 0 93 0.0 0.0 0.0 100.0 0.0 0.0 0.0 100.0
Total 819 13 284 1,116 4 2 3 0.4 0.2 1.1 99.2 7 4 1 0.6 0.5 0.4 98.9
Enterococci Vancomycin 51 51 0.0 0.0 0.0 100.0 2 3.9 0.0 0.0 96.1
Teicoplanin 51 51 0.0 0.0 0.0 100.0 0.0 0.0 0.0 100.0
Tetracycline 19 32 51 0.0 0.0 0.0 100.0 1 2.0 0.0 0.0 98.0
Total 121 0 32 153 0 0 0 0.0 0.0 0.0 100.0 3 2.0 0.0 0.0 98.0
All 2,270 107 782 3,159 89 4 13 2.8 0.2 1.7 97.0 94 6 5 3.0 0.3 0.6 97.0
a

Abbreviations: S, susceptible; I, intermediate; R, resistant.